Jade Biosciences, Inc. (JBIO) › Operating Cash FlowJade Biosciences, Inc. (JBIO) — Operating Cash FlowAnnual figures by period end, from SEC filings.2020-12-31: -$7.86M2021-12-31: -$27.40M2022-12-31: -$39.12M2023-12-31: -$56.78M2024-12-31: -$71.20M2025-12-31: -$94.69M-$94.69M2020-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$94.69M—2026-03-06From 2025-01-012024-12-31-$71.20M—2025-03-27From 2024-01-012023-12-31-$56.78M—2025-03-27From 2023-01-012022-12-31-$39.12M—2024-03-25From 2022-01-012021-12-31-$27.40M—2023-03-29From 2021-01-012020-12-31-$7.86M—2022-03-30From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)